Humacyte, Inc. Increase (Decrease) in Prepaid Expense
Humacyte, Inc. (HUMA) reported Increase (Decrease) in Prepaid Expense of $2.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-12
- Humacyte, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $864.00K.
- Humacyte, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $1.44M.
- Humacyte, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $968.00K, a 214.29% increase year-over-year.
- Humacyte, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $64.00K.
- Humacyte, Inc. increase (decrease) in prepaid expense for fiscal 2025 was $527.00K.
- Humacyte, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$88.00K, a 122.68% decline from fiscal 2023.
- Humacyte, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $388.00K.
- Humacyte, Inc. increase (decrease) in prepaid expense for fiscal 2022 was -$1.36M, a 162.74% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.30M 10-Q · filed 2026-08-12 | $3.27M derived: sum of 3 quarters · filed 2026-08-12 | $3.33M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-13 | $2.40M derived: sum of 2 quarters · filed 2026-05-13 | $2.47M derived: sum of 3 quarters · filed 2026-05-13 | $2.36M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $968.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.03M derived: sum of 2 quarters · filed 2026-03-27 | $919.00K derived: sum of 3 quarters · filed 2026-08-12 | $527.00K 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$49.00K derived: sum of 2 quarters · filed 2026-08-12 | -$441.00K 10-Q · filed 2025-11-12 | -$133.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$505.00K 10-Q · filed 2026-08-12 | -$197.00K derived: sum of 3 quarters · filed 2026-08-12 | -$310.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$392.00K 10-Q · filed 2026-05-13 | -$84.00K derived: sum of 2 quarters · filed 2026-05-13 | -$197.00K derived: sum of 3 quarters · filed 2026-05-13 | -$71.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $195.00K derived: sum of 2 quarters · filed 2026-03-27 | $321.00K derived: sum of 3 quarters · filed 2026-03-27 | -$88.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $13.00K derived: sum of 2 quarters · filed 2025-11-12 | -$396.00K 10-Q · filed 2025-11-12 | -$431.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$283.00K 10-Q · filed 2025-08-11 | -$318.00K derived: sum of 3 quarters · filed 2025-08-11 | -$3.56M derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | -$409.00K 10-Q · filed 2025-05-13 | -$444.00K derived: sum of 2 quarters · filed 2025-05-13 | -$3.68M derived: sum of 3 quarters · filed 2025-05-13 | $99.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.27M derived: sum of 2 quarters · filed 2025-03-31 | $508.00K derived: sum of 3 quarters · filed 2025-03-31 | $388.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $543.00K derived: sum of 2 quarters · filed 2024-11-08 | $423.00K 10-Q · filed 2024-11-08 | -$129.00K derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $3.66M 10-Q · filed 2024-08-13 | $3.11M derived: sum of 3 quarters · filed 2024-08-13 | $3.26M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | -$120.00K 10-Q · filed 2024-05-13 | -$672.00K derived: sum of 2 quarters · filed 2024-05-13 | -$516.00K derived: sum of 3 quarters · filed 2024-05-13 | -$662.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | -$552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$396.00K derived: sum of 2 quarters · filed 2024-03-28 | -$542.00K derived: sum of 3 quarters · filed 2024-03-28 | -$1.36M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $10.00K derived: sum of 2 quarters · filed 2023-11-09 | -$812.00K 10-Q · filed 2023-11-09 | -$640.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$968.00K 10-Q · filed 2023-08-14 | -$796.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.13M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$822.00K 10-Q · filed 2023-05-12 | -$650.00K derived: sum of 2 quarters · filed 2023-05-12 | $1.28M derived: sum of 3 quarters · filed 2023-05-12 | $1.36M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.10M derived: sum of 2 quarters · filed 2023-03-24 | $2.18M derived: sum of 3 quarters · filed 2023-03-24 | $2.17M 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.01M derived: sum of 2 quarters · filed 2022-11-10 | $2.00M 10-Q · filed 2022-11-10 | $2.12M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $75.00K 10-Q · filed 2022-08-12 | -$54.20K 10-Q · filed 2021-08-16 | $193.31K derived: sum of 3 quarters · filed 2022-08-12 | $223.98K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-13 | -$24.39K 10-Q · filed 2021-05-17 | $111.31K derived: sum of 2 quarters · filed 2022-05-13 | $141.98K derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $118.31K derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-14 | $148.98K 10-K/A · filed 2021-05-14 | $767.00K 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $30.67K 10-Q · filed 2020-11-13 | $654.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |